Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 201

1.

Transglutaminase diseases: from biochemistry to the bedside.

Lorand L, Iismaa SE.

FASEB J. 2019 Jan;33(1):3-12. doi: 10.1096/fj.201801544R. Erratum in: FASEB J. 2019 Mar;33(3):4653.

PMID:
30593123
2.

Transglutaminase 2 is essential for adherence of Porphyromonas gingivalis to host cells.

Boisvert H, Lorand L, Duncan MJ.

Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5355-60. doi: 10.1073/pnas.1402740111. Epub 2014 Mar 24.

3.

Transglutaminase-mediated remodeling of the human erythrocyte membrane skeleton: relevance for erythrocyte diseases with shortened cell lifespan.

Lorand L, Murthy SN, Khan AA, Xue W, Lockridge O, Chishti AH.

Adv Enzymol Relat Areas Mol Biol. 2011;78:385-414. Review. No abstract available.

4.

Climate change and the integrity of science.

Gleick PH, Adams RM, Amasino RM, Anders E, Anderson DJ, Anderson WW, Anselin LE, Arroyo MK, Asfaw B, Ayala FJ, Bax A, Bebbington AJ, Bell G, Bennett MV, Bennetzen JL, Berenbaum MR, Berlin OB, Bjorkman PJ, Blackburn E, Blamont JE, Botchan MR, Boyer JS, Boyle EA, Branton D, Briggs SP, Briggs WR, Brill WJ, Britten RJ, Broecker WS, Brown JH, Brown PO, Brunger AT, Cairns J Jr, Canfield DE, Carpenter SR, Carrington JC, Cashmore AR, Castilla JC, Cazenave A, Chapin FS 3rd, Ciechanover AJ, Clapham DE, Clark WC, Clayton RN, Coe MD, Conwell EM, Cowling EB, Cowling RM, Cox CS, Croteau RB, Crothers DM, Crutzen PJ, Daily GC, Dalrymple GB, Dangl JL, Darst SA, Davies DR, Davis MB, De Camilli PV, Dean C, DeFries RS, Deisenhofer J, Delmer DP, DeLong EF, DeRosier DJ, Diener TO, Dirzo R, Dixon JE, Donoghue MJ, Doolittle RF, Dunne T, Ehrlich PR, Eisenstadt SN, Eisner T, Emanuel KA, Englander SW, Ernst WG, Falkowski PG, Feher G, Ferejohn JA, Fersht A, Fischer EH, Fischer R, Flannery KV, Frank J, Frey PA, Fridovich I, Frieden C, Futuyma DJ, Gardner WR, Garrett CJ, Gilbert W, Goldberg RB, Goodenough WH, Goodman CS, Goodman M, Greengard P, Hake S, Hammel G, Hanson S, Harrison SC, Hart SR, Hartl DL, Haselkorn R, Hawkes K, Hayes JM, Hille B, Hökfelt T, House JS, Hout M, Hunten DM, Izquierdo IA, Jagendorf AT, Janzen DH, Jeanloz R, Jencks CS, Jury WA, Kaback HR, Kailath T, Kay P, Kay SA, Kennedy D, Kerr A, Kessler RC, Khush GS, Kieffer SW, Kirch PV, Kirk K, Kivelson MG, Klinman JP, Klug A, Knopoff L, Kornberg H, Kutzbach JE, Lagarias JC, Lambeck K, Landy A, Langmuir CH, Larkins BA, Le Pichon XT, Lenski RE, Leopold EB, Levin SA, Levitt M, Likens GE, Lippincott-Schwartz J, Lorand L, Lovejoy CO, Lynch M, Mabogunje AL, Malone TF, Manabe S, Marcus J, Massey DS, McWilliams JC, Medina E, Melosh HJ, Meltzer DJ, Michener CD, Miles EL, Mooney HA, Moore PB, Morel FM, Mosley-Thompson ES, Moss B, Munk WH, Myers N, Nair GB, Nathans J, Nester EW, Nicoll RA, Novick RP, O'Connell JF, Olsen PE, Opdyke ND, Oster GF, Ostrom E, Pace NR, Paine RT, Palmiter RD, Pedlosky J, Petsko GA, Pettengill GH, Philander SG, Piperno DR, Pollard TD, Price PB Jr, Reichard PA, Reskin BF, Ricklefs RE, Rivest RL, Roberts JD, Romney AK, Rossmann MG, Russell DW, Rutter WJ, Sabloff JA, Sagdeev RZ, Sahlins MD, Salmond A, Sanes JR, Schekman R, Schellnhuber J, Schindler DW, Schmitt J, Schneider SH, Schramm VL, Sederoff RR, Shatz CJ, Sherman F, Sidman RL, Sieh K, Simons EL, Singer BH, Singer MF, Skyrms B, Sleep NH, Smith BD, Snyder SH, Sokal RR, Spencer CS, Steitz TA, Strier KB, Südhof TC, Taylor SS, Terborgh J, Thomas DH, Thompson LG, Tjian RT, Turner MG, Uyeda S, Valentine JW, Valentine JS, Van Etten JL, van Holde KE, Vaughan M, Verba S, von Hippel PH, Wake DB, Walker A, Walker JE, Watson EB, Watson PJ, Weigel D, Wessler SR, West-Eberhard MJ, White TD, Wilson WJ, Wolfenden RV, Wood JA, Woodwell GM, Wright HE Jr, Wu C, Wunsch C, Zoback ML.

Science. 2010 May 7;328(5979):689-90. doi: 10.1126/science.328.5979.689. No abstract available. Erratum in: Science. 2010 May 14;328(5980):826.

5.

Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders.

Iismaa SE, Mearns BM, Lorand L, Graham RM.

Physiol Rev. 2009 Jul;89(3):991-1023. doi: 10.1152/physrev.00044.2008. Review.

6.

Selectivity in the post-translational, transglutaminase-dependent acylation of lysine residues.

Murthy SN, Lukas TJ, Jardetzky TS, Lorand L.

Biochemistry. 2009 Mar 31;48(12):2654-60. doi: 10.1021/bi802323z.

PMID:
19222223
7.

Micromechanical properties of keratin intermediate filament networks.

Sivaramakrishnan S, DeGiulio JV, Lorand L, Goldman RD, Ridge KM.

Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):889-94. doi: 10.1073/pnas.0710728105. Epub 2008 Jan 16.

8.

Crosslinks in blood: transglutaminase and beyond.

Lorand L.

FASEB J. 2007 Jun;21(8):1627-32. Review. No abstract available.

PMID:
17538029
9.

Mechanism of allosteric regulation of transglutaminase 2 by GTP.

Begg GE, Carrington L, Stokes PH, Matthews JM, Wouters MA, Husain A, Lorand L, Iismaa SE, Graham RM.

Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19683-8. Epub 2006 Dec 18.

10.

Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.

Salmi TT, Collin P, Korponay-Szabó IR, Laurila K, Partanen J, Huhtala H, Király R, Lorand L, Reunala T, Mäki M, Kaukinen K.

Gut. 2006 Dec;55(12):1746-53. Epub 2006 Mar 29.

11.

Factor XIII and the clotting of fibrinogen: from basic research to medicine.

Lorand L.

J Thromb Haemost. 2005 Jul;3(7):1337-48. Review. No abstract available.

12.

Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase.

Hang J, Zemskov EA, Lorand L, Belkin AM.

J Biol Chem. 2005 Jun 24;280(25):23675-83. Epub 2005 Apr 22.

13.

Deciphering the physiological pathway of clotting of fibrinogen in blood plasma.

Lorand L.

Biophys Chem. 2004 Dec 20;112(2-3):141-5.

PMID:
15572241
14.

Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk).

Lefebvre P, Velasco PT, Dear A, Lounes KC, Lord ST, Brennan SO, Green D, Lorand L.

Blood. 2004 Apr 1;103(7):2571-6. Epub 2003 Nov 13.

PMID:
14615374
15.

Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases.

Iismaa SE, Holman S, Wouters MA, Lorand L, Graham RM, Husain A.

Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12636-41. Epub 2003 Oct 17.

16.

Activation of transglutaminase in mu-calpain null erythrocytes.

O'Neill GM, Prasanna Murthy SN, Lorand L, Khanna R, Liu SC, Hanspal M, Hanada T, Chishti AH.

Biochem Biophys Res Commun. 2003 Jul 25;307(2):327-31.

PMID:
12859959
17.

Transglutaminases: crosslinking enzymes with pleiotropic functions.

Lorand L, Graham RM.

Nat Rev Mol Cell Biol. 2003 Feb;4(2):140-56. Review.

PMID:
12563291
18.

Intracranial hemorrhage in systemic lupus erythematosus associated with an autoantibody against actor XIII.

Lorand L, Velasco PT, Hill JM, Hoffmeister KJ, Kaye FJ.

Thromb Haemost. 2002 Dec;88(6):919-23.

PMID:
12529739
19.

Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity.

Murthy SN, Iismaa S, Begg G, Freymann DM, Graham RM, Lorand L.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2738-42. Epub 2002 Feb 26.

20.

Transglutaminase: remembering Heinrich Waelsch.

Lorand L.

Neurochem Int. 2002 Jan;40(1):7-12. No abstract available.

PMID:
11833484

Supplemental Content

Loading ...
Support Center